TickerFacts.

Grace Therapeutics, Inc. (GRCE): Net Income

Annual figures by period end, from SEC filings.

-$7.79M
Year ended 2026-03-31
-$20.22M
Trailing 12 months to 2026-06-30
2019-03-31: -$39.37M2020-03-31: -$25.51M2021-03-31: -$19.68M2022-03-31: -$9.82M2023-03-31: -$42.43M2024-03-31: -$12.85M2025-03-31: -$9.57M2026-03-31: -$7.79M-$7.79M
2019-03-31 Net Income (USD) 2026-03-31
Period endedNet IncomeChange YoYSource filing
2026-03-31-$7.79Mn/m2026-06-18, From 2025-04-01
2025-03-31-$9.57Mn/m2026-06-18, From 2024-04-01
2024-03-31-$12.85Mn/m2025-06-23, From 2023-04-01
2023-03-31-$42.43Mn/m2024-06-21, From 2022-04-01
2022-03-31-$9.82Mn/m2023-06-23, From 2021-04-01
2021-03-31-$19.68Mn/m2022-06-21, From 2020-04-01
2020-03-31-$25.51Mn/m2021-06-22, From 2019-04-01
2019-03-31-$39.37Mn/a2020-06-29, From 2018-04-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Grace Therapeutics, Inc. (GRCE)2026-03-31-$7.79Mn/m
Context Therapeutics Inc. (CNTX)2025-12-31-$36.12Mn/m
Spero Therapeutics, Inc. (SPRO)2025-12-31$8.57Mn/m
Werewolf Therapeutics, Inc. (HOWL)2025-12-31-$60.82Mn/m
Corvus Pharmaceuticals, Inc. (CRVS)2025-12-31-$15.28Mn/m
Rallybio Corp (RLYB)2025-12-31-$8.98Mn/m
OnKure Therapeutics, Inc. (OKUR)2025-12-31-$59.52Mn/m
Lifevantage Corp (LFVN)2026-06-30$5.07M-48.3%
AN2 Therapeutics, Inc. (ANTX)2025-12-31-$35.17Mn/m

Compare GRCE, CNTX, SPRO, HOWL side by side · Screen every company in Pharmaceutical Preparations ↗